Innovation

July 18, 2023

The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer and Merck

Illumina Inc., in collaboration with Nashville Biosciences LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, have announced the five founding new members of the Alliance for Genomic Discovery.

Ann Walker, Research Assistant III, spins blood samples on a carousel prior to DNA extraction.
July 18, 2023

Alliance for Genomic Discovery FAQs

Here are frequently asked questions about Vanderbilt University Medical Center’s Alliance for Genomic Discovery.

June 8, 2023

Novel technology helps identify parathyroids during pediatric endocrine surgery

A Vanderbilt study found that a probe technology that uses near-infrared autofluorescent lighting helps positively identify and preserve childrens’ parathyroids during endocrine surgery.

May 22, 2023

Project aims to improve ear disease diagnoses with objective machine learning techniques

A new project, funded by the National Institutes of Health (NIH), National Institute on Deafness and Other Communication Disorders (NIDCD) and led by Aaron Moberly, MD, and Metin Gurcan, PhD, professor and director of the Center for Biomedical Informatics and the Clinical Image Analysis Lab at Wake Forest University School of Medicine, aims to develop machine learning applications to analyze eardrum videos collected with a digital otoscope.

May 11, 2023

Procedure uses patient’s own growth to treat scoliosis

Vanderbilt pediatric orthopaedic surgeons are the first in Tennessee to perform an innovative procedure to treat scoliosis that uses the patient’s own growth to correct the curve.

March 2, 2023

VUMC joins group to accelerate implementation of research findings to improve patient outcomes

Vanderbilt University Medical Center is part of a select group of health systems nationwide brought together to accelerate the implementation of medical research results that will improve patient outcomes.